tiprankstipranks
Trending News
More News >
Biodexa Pharmaceuticals (BDRX)
NASDAQ:BDRX
US Market

Biodexa Pharmaceuticals (BDRX) Ratios

Compare
492 Followers

Biodexa Pharmaceuticals Ratios

BDRX's free cash flow for Q2 2024 was £0.00. For the 2024 fiscal year, BDRX's free cash flow was decreased by £ and operating cash flow was £0.00. See a summary of the company’s cash flow.
Ratios
TTM
Dec 23Dec 22Dec 21Dec 20
Liquidity Ratios
Current Ratio
2.47 2.47 6.39 3.10 2.42
Quick Ratio
2.47 2.47 6.39 3.56 2.42
Cash Ratio
1.49 1.49 5.46 2.52 1.93
Solvency Ratio
-3.09 -3.09 -2.06 -6.77 -0.69
Operating Cash Flow Ratio
-3.71 -3.71 -3.26 -3.11 -1.15
Short-Term Operating Cash Flow Coverage
0.00 0.00 0.00 -86.93 -36.25
Net Current Asset Value
£ 2.33M£ 2.33M£ 9.30M£ 6.18M£ 2.40M
Leverage Ratios
Debt-to-Assets Ratio
0.11 0.11 0.06 0.03 0.20
Debt-to-Equity Ratio
0.20 0.20 0.07 0.04 0.31
Debt-to-Capital Ratio
0.16 0.16 0.07 0.04 0.24
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 0.00 0.20
Financial Leverage Ratio
1.75 1.75 1.24 1.46 1.58
Debt Service Coverage Ratio
-155.23 -155.23 -143.30 -166.67 -41.04
Interest Coverage Ratio
-168.53 -168.53 -159.05 -313.85 -116.68
Debt to Market Cap
0.00 0.00 0.00 0.15 8.29
Interest Debt Per Share
54.80 54.80 80.45 54.90 2.70K
Net Debt to EBITDA
0.30 0.30 1.64 0.33 0.51
Profitability Margins
Gross Profit Margin
-631.19%-631.19%-705.19%-1669.10%-1063.65%
EBIT Margin
-1206.72%-1206.72%-1048.79%-6832.65%-1606.23%
EBITDA Margin
-1057.94%-1057.94%-979.07%-6477.84%-1415.58%
Operating Profit Margin
-1277.83%-1277.83%-1210.73%-3111.08%-1679.23%
Pretax Profit Margin
-1214.31%-1214.31%-1056.40%-6842.57%-1620.62%
Net Profit Margin
-1095.28%-1095.28%-944.64%-6469.10%-1355.79%
Continuous Operations Profit Margin
-1095.28%-1095.28%-944.64%-6469.10%-1355.79%
Net Income Per EBT
90.20%90.20%89.42%94.54%83.66%
EBT Per EBIT
95.03%95.03%87.25%219.94%96.51%
Return on Assets (ROA)
-138.57%-138.57%-42.28%-226.03%-29.58%
Return on Equity (ROE)
-242.13%-242.13%-52.24%-330.29%-46.72%
Return on Capital Employed (ROCE)
-246.40%-246.40%-63.20%-156.28%-44.86%
Return on Invested Capital (ROIC)
-259.05%-259.05%-68.98%-160.12%-51.36%
Return on Tangible Assets
-138.72%-138.72%-42.28%-226.03%-49.35%
Earnings Yield
-3805.27%-3805.27%-699.05%-3027.46%-1534.76%
Efficiency Ratios
Receivables Turnover
2.12 2.12 17.52 3.61 30.64
Payables Turnover
15.08 15.08 9.60 18.01 10.82
Inventory Turnover
5.11M 5.11M 4.65M -4.41 7.84M
Fixed Asset Turnover
0.84 0.84 0.50 0.63 0.31
Asset Turnover
0.13 0.13 0.04 0.03 0.02
Working Capital Turnover Ratio
0.11 0.11 0.07 0.05 0.12
Cash Conversion Cycle
147.59 147.59 -17.20 -1.95 -21.83
Days of Sales Outstanding
171.80 171.80 20.84 101.09 11.91
Days of Inventory Outstanding
<0.01 <0.01 <0.01 -82.77 <0.01
Days of Payables Outstanding
24.21 24.21 38.04 20.27 33.74
Operating Cycle
171.80 171.80 20.84 18.32 11.91
Cash Flow Ratios
Operating Cash Flow Per Share
-570.50 -570.50 -596.74 -1.74K -2.83K
Free Cash Flow Per Share
-575.52 -575.52 -628.53 -1.78K -2.97K
CapEx Per Share
5.02 5.02 31.78 39.03 139.24
Free Cash Flow to Operating Cash Flow
1.01 1.01 1.05 1.02 1.05
Dividend Paid and CapEx Coverage Ratio
-113.68 -113.68 -18.77 -44.50 -20.34
Capital Expenditure Coverage Ratio
-113.68 -113.68 -18.77 -44.50 -20.34
Operating Cash Flow Coverage Ratio
-11.29 -11.29 -7.84 -35.77 -1.07
Operating Cash Flow to Sales Ratio
-10.08 -10.08 -10.39 -27.12 -9.63
Free Cash Flow Yield
-8.83%-8.83%-2.03%-3.24%-2.86%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-0.03 -0.03 -0.14 -0.03 -0.07
Price-to-Sales (P/S) Ratio
0.29 0.29 1.35 2.14 0.88
Price-to-Book (P/B) Ratio
0.06 0.06 0.07 0.11 0.03
Price-to-Free Cash Flow (P/FCF) Ratio
-0.03 -0.03 -0.12 -0.08 -0.09
Price-to-Operating Cash Flow Ratio
-0.03 -0.03 -0.13 -0.08 -0.09
Price-to-Earnings Growth (PEG) Ratio
>-0.01 >-0.01 <0.01 >-0.01 0.00
Price-to-Fair Value
0.06 0.06 0.07 0.11 0.03
Enterprise Value Multiple
0.27 0.27 1.50 0.29 0.45
Enterprise Value
78.27M 78.27M 303.13M 285.88M 233.31M
EV to EBITDA
-10.58 -10.58 -53.57 -12.87 -24.45
EV to Sales
111.97 111.97 524.45 833.48 346.16
EV to Free Cash Flow
-11.01 -11.01 -47.90 -30.06 -34.27
EV to Operating Cash Flow
-11.10 -11.10 -50.45 -30.74 -35.96
Tangible Book Value Per Share
255.46 255.46 1.04K 1.25K 3.13K
Shareholders’ Equity Per Share
255.95 255.95 1.04K 1.25K 8.54K
Tax and Other Ratios
Effective Tax Rate
-0.10 -0.10 -0.11 -0.05 -0.16
Revenue Per Share
56.58 56.58 57.41 64.05 294.19
Net Income Per Share
-619.72 -619.72 -542.31 -4.14K -3.99K
Tax Burden
0.90 0.90 0.89 0.95 0.84
Interest Burden
1.01 1.01 1.01 1.00 1.01
Research & Development to Revenue
7.31 7.31 8.05 47.07 11.64
SG&A to Revenue
6.50 6.50 5.10 14.45 5.70
Stock-Based Compensation to Revenue
0.18 0.18 0.15 -1.18 -0.05
Income Quality
0.92 0.92 1.10 0.42 0.64
Currency in GBP
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis